Article Text
How to do it
Treatment of the unknown patient: insights from acute stroke
Abstract
When an unidentified patient who cannot communicate presents with symptoms and signs suggesting an acute stroke, the decision to thrombolyse is a particular challenge. In a time-pressured environment, clinicians need clear thought processes for diagnosis and treatment. Ethical considerations, diagnosis, identity and previous history, contraindications, time of symptom onset (EDICT) can help decision-making in this situation.
- thrombolysis
- ischemic stroke
- unknown
- identification
- aphasia
Statistics from Altmetric.com
Footnotes
Twitter @NeuroSimon
Contributors SMB and MSR devised the article. All authors equally contributed to the creation and writing of the article.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by William Whiteley, Edinburgh, UK.
Read the full text or download the PDF:
Other content recommended for you
- Low relative diffusion weighted image signal intensity can predict good prognosis after endovascular thrombectomy in patients with acute ischemic stroke
- Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging
- Factors associated with prehospital delay in acute stroke
- Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
- Management of a wake-up stroke
- Validity of a computerised five-level emergency triage system for patients with acute ischaemic stroke
- Collateral flow as causative of good outcomes in endovascular stroke therapy
- Thrombolysis in patients with WAKE-UP or unknown time of stroke onset: ready for prime time?
- Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome
- The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies